Keywords: Zentiva, Sanofi, Turkey, R&D base, Production, Export

Turkey to become Sanofi generics unit Zentiva’s R&D base

Article | 28 June 2011

Print This

Czech Republic-headquartered Zentiva, the generics arm of French drug major Sanofi (Euronext: SAN), has picked Turkey as the location to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in